Summary: Dr. Frederick Barrett discusses recent and upcoming studies into psilocybin -- the psychoactive ingredient that puts the "magic" in magic mushrooms. This currently "Schedule 1" drug, in addition to reasonably reliably provoking mystical experiences in users, also shows promise as a therapeutic treatment for depression, PTSD, and hospice care. Dr. Barrett and colleagues at Johns Hopkins Medical Center are at the forefront of the latest research.
